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Introduction
Hypokalemic periodic paralysis is an autosomal dominant 
disease characterized by muscle weakness or paralysis 
with a matching fall in serum potassium levels. Attacks 
often occur in adolescence and are induced by strenuous 
exercise, high carbohydrate or high sodium meal content, 
sudden changes in temperature and cold temperatures. 
Weakness may be mild and limited to certain muscle 
groups, or more severe full body paralysis. Attacks may 
last for a few hours or several days. Some people only 
develop symptoms of periodic paralysis due to hyperthy-
roidism (1). People with hypokalemic periodic paralysis 
maybe misdiagnosed as having a conversion disorder 
since the weakness is muscle-based and does not corre-
spond to any nerve or spinal root distributions (2). Treat-
ment of hypokalemic periodic paralysis focuses on reliev-
ing acute symptoms and preventing further attacks by 
avoiding carbohydrate-rich meals and strenuous exercise. 
Paralysis attacks can be managed by drinking one of vari-
ous potassium salts dissolved in water. Rapidly absorbed 
boluses of liquid potassium are generally needed to stop 
an attack, but some patients also find maintenance results 
with time-released tablets. Intravenous potassium is sel-
dom justified unless the patient is unable to swallow (3). 
Potassium chloride is extensively used as a potassium sup-
plement, mostly in the form of salt substitute. Therapeuti-
cally, both oral and intravenous forms of potassium are 
used. Treatment of hypokalemia in stable patients who are 
able to tolerate oral intake can be done orally by food rich 
in potassium, salt substitutes and potassium supplements. 
IV replacement is appropriate for severe hypokalemia and 
infusion rate should be no greater than 40 mEq/h. Cardiac 
manifestations are the most serious side effect of hyperka-
lemia and rapid KCL infusion, cardiac dysrhythmia such 
as VF, complete heart block and asystol may also occur 
(4). Here, we present the case of intravenous bolus injec-
tion of potassium chloride into cubital vein in a young 
man with hypokalemic periodic paralysis.
Case report
A 29-year-old healthy man was admitted to the emer-
gency department (bodyweight, 78 kg) complaining of 
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Abstract
Hypokalemic periodic paralysis is anautosomal dominantdisease characterized by muscle 
weakness or paralysis with a matching fall in blood potassium levels. Paralysis attacks 
often occur in adolescence and are induced by strenuous exercise followed by rest, 
high carbohydrateor high sodiummeal content, sudden changes in temperature, and 
even excitement, noise, flashing lights and cold temperatures. Despite global daily use 
of intravenous and oral potassium in the treatment of patients, data about intravenous 
bolus potassium is rare. Here we report a 29-year-old man complaining of weakness in the 
upper and lower limbs. By initial diagnosis of periodic hypokalemic paralysis, potassium 
chloride was ordered by oral route. After a few minutes, we heard patient screaming in 
pain. He complained of severe acute pain in peripheral intravenous line, palpitation and 
dyspnea. We noticed that potassium chloride vial was infused directly via cubital vein in 
few minutes erroneously. Physical exam revealed sinus tachycardia and hypertension. We 
began hyperkalemia treatment immediately. With appropriate treatment,the patient was 
discharged with good condition after 12 hours of admission.
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the weakness in the upper and lower limbs. On arrival, 
the patient was hemodynamically stable. Oral tempera-
ture was 37.5°C (99.5°F), pulse rate 78 bpm with a sinus 
rhythm, blood pressure 125/75 mm Hg, and his respira-
tory rate was 14 breaths per minute. The abdomen and 
bowel sounds were normal. The initial oxygen saturation 
was 94% (in room air). He was alert and awake with no 
apparent distress. In clinical examination, forces of up-
per limbs were 3/5 but lower limbs were 4/5. Weakness 
of upper limbs was more significant. By initial diagnosis 
of periodic hypokalemic paralysis,potassium chloride (50 
cc of 15 % [7.5 g]) was ordered by oral route. After a few 
minutes, we heard patient screaming in pain. We quickly 
attended the patient’s bed and it was very surprising to see 
him severely agitated with severe acute pain in peripheral 
IV line, palpitation and dyspnea. Immediately, we found 
that all of potassium chloride vial was infused directly via 
right cubital vein in few minutes erroneously. After that, 
the patient was transferred to CPR part immediately. He 
went under cardiac monitoring and received oxygen by 
nasal canola. He had sinus tachycardia (HR = 140), HTN 
(160/90) and tachypnea (RR: 28). Calcium gluconate solu-
tion (10 cc of 10%) was intravenously injected in 2 min-
utes and one litre of normal saline was immediately in-
fused. Only 15-20 minutes after injection of calcium glu-
conate and serum, dyspnea and palpitation became better, 
but 20 minutes latter symptoms of the patient flared up. 
Due to this situation another calcium gluconate solution 
was intravenously reinjected and one litre of normal saline 
was ordered again for one hour. The color Doppler sonog-
raphy of the right upper extremity showed no thrombosis 
in superficial veins. Muscle weakness was healed in the 
first few minutes. A 12-lead electrocardiogram revealed 
sinus tachycardia at a rate of 140 bpm (Figure 1). Lab data 
in admission time: a complete blood count in patient was 
normal except for a mildly elevated white blood cell count 
of 11.2× 103/µL (11.2× 109/L), with 50% neutrophils, 48% 
lymphocytes, 1% monocytes, and 1% eosinophils, hemo-
globin 15.3 g/dL, hematocrit 44.5%. His serum blood urea 
nitrogen, creatinine, creatinine kinase, and liver function 
tests were normal (sodium 141 mEq/L, potassium 3.2 
mEq/L, calcium [total] 9 mg/dL, magnesium 1.7 mg/dL). 
Serum glucose was 130 mg/dL. In the blood sample taken 
after the first injection of calcium gluconate, potassium 
was 4 and 3 hours before discharge, potassium level was 
3.8. Patient was discharged 12 hours after admission by 
diagnosis of periodic hypokalemic paralysis with recom-
mendation of low carbohydrate and high potassium diet. 
He was advised to apply warm compress and ibuprofen 
400 mg orally every 6 hours was prescribed as well.
Discussion
Intentional intravenous potassium intoxication or intoxi-
cation due to medical treatment is a rare and very dan-
gerous condition. The risks of intravenous potassium 
chloride injections are well known. Rapid or high dose 
injection can cause cardiac arrest within minutes. The ef-
fect of hyperkalemia on the heart is complex – virtually 
any arrhythmia may be observed (5). Hyperkalemia cause 
various electrocardiography (ECG) changes, depending 
on potassium serum concentration. So, ECG is essential to 
detect and follow these abnormalities. There is a close cor-
relation between plasmatic potassium concentration and 
ECG changes with great variability (6). Rapid diagnosis 
and treatment of intravenous potassium poisoning by ad-
ministration of calcium gluconate and other medications 
as beta-2-adrenergic agonists and insulin-glucose im-
proved outcome (6). The ion exchange resins and diuret-
ics have no role in this type of care. Their delayed effect 
dedicate them to the treatment of chronic moderate hy-
perkalemia. Hemodialysis performed in emergency is the 
standard treatment of hyperkalemia, particularly in cases 
of severe hyperkalemia which quickly set up or with high 
risk of reconstitution (hemolysis, tissue catabolism) (6). 
Most toxic hyperkalemia described in texts and case re-
ports are due to sustained-release potassium supplements, 
side effects, or overdose of medical treatments (7-9).The 
true incidence of potassium-related fatalities and incidents 
is unknown. Fatal intravenous injection of potassium pro-
duces no specific anatomic changes and if any findings, it 
is subtle (10). Nilsson et al reported a case of a 30-year-
old woman who was admitted to the emergency depart-
ment due to the ingestion of 300 slow-release tablets of 
potassium-chloride. Her serum potassium was 9.5 mmol/l 
and cardiovascular function was poor. Despite intensive 
medical treatment and gastric lavage, serum potassium re-
mained very high (9 mmol/l). Although hemodialysis was 
initiated but despite ongoing dialysis, potassium increased 
to 10.3 mmol/l. A parallel dialysis was started and after 4 
hours of parallel dialysis, serum potassium decreased to 
6.4 mmol/l. An x-ray revealed large amounts of pills re-
maining in the stomach and the surgeon removed about 
200 pills with laparotomy. The patient recovered slowly 
thereafter, but later developed a gastric stricture and PTE 
(11). Battefort et al in 2012 reported a case of a 20-year-old 
nurse student with IV injection of four vials of potassium 
chloride (20 mL, 10%) and subsequent cardiac arrest with 
asystol rhythm. Initial resuscitation with epinephrine and 
sodium bicarbonate resulted in the recovery and effective 
cardiac activity without any squeal. They concluded that 
the advanced resuscitation with the use of a specific treat-
ment helped to resuscitate the patient (12). Bertol et al in 
2012 reported a case of a 41-year-old man who died due Figure 1. Twelve-lead electrocardiogram revealed sinus tachycardia.
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to intravenous injection of potassium chloride (13). In our 
case with underlying hypokalemia, sins tachycardia and 
no renal dysfunction it seems that hyperkalemia will be 
transient and we prefer to use just calcium gluconate to 
protect cardiac cell and hydration. We avoid using other 
treatment options such as insulin–glucose, beta-2-adren-
ergic agonists and bicarbonate or the ion exchange resins, 
diuretics and hemodialysis.
Conclusion
There are some case reports of life-threatening dysrhyth-
mia and death due to rapid IV potassium infusion and 
oral high dose ingestion. Immediate recognition and spe-
cific treatment are vital to survive patients.
Ethical issues
Confidentiality of patient information was maintained. 
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